Bas Blits

1.1k citations

22 papers · 869 indexed · h-index 15

Impact in

Developmental Neuroscience top 5%
- Neurogenesis and neuroplasticity mechanisms
Cellular and Molecular Neuroscience top 5%
- Nerve injury and regeneration
- Genetic Neurodegenerative Diseases

Papers in ⓘ

Cellular and Molecular Neuroscience 9
- Nerve injury and regeneration 6
Immunology and Allergy 2
- Cell Adhesion Molecules Research 2

Co-authors: Harald Petry (9 shared papers)Brendan J. Battersby (1 shared paper)M. Pilar Bayona‐Bafaluy (1 shared paper)Eric A. Shoubridge (1 shared paper)Carlos T. Moraes (1 shared paper)James W. Fawcett (3 shared papers)Melissa R. Andrews (2 shared papers)Charles ffrench‐Constant (2 shared papers)
Journals: Gene Therapy (4 papers)Molecular Therapy (3 papers)Human Gene Therapy (1 paper)Journal of Neuroscience (1 paper)Brain (1 paper)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Bas Blits

22 papers receiving 848 citations

Peers

Countries citing papers authored by Bas Blits

Since Specialization

Citations

This map shows the geographic impact of Bas Blits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas Blits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas Blits more than expected).

Fields of papers citing papers by Bas Blits

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bas Blits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas Blits. The network helps show where Bas Blits may publish in the future.

Co-authors

The 25 scholars most cited alongside Bas Blits, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bas Blits Line = papers co-authored together Bas Blits links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	α9 Integrin Promotes Neurite Outgrowth on Tenascin-C and Enhances Sensory Axon Regeneration Journal of Neuroscience ·Melissa R. Andrews, Stefan Czvitkovich, Elisa Dassie, Christina Francisca Vogelaar, Andréas Faissner, Bas Blits, Fred H. Gage, Charles ffrench‐Constant, James W. Fawcett	2009	134
2	Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease Proceedings of the National Academy of Sciences ·M. Pilar Bayona‐Bafaluy, Bas Blits, Brendan J. Battersby, Eric A. Shoubridge, Carlos T. Moraes	2005	133
3	AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington’s Disease Minipig Model Molecular Therapy ·Melvin M. Evers, Jana Miniarikova, Štefan Juhás, Astrid Vallès, Božena Bohuslavová, Jana Juhásová, Helena Kupcová Skalníková, Petr Vodička, Ivona Valeková, Cynthia Brouwers, Bas Blits, Jacek Lubelski, Hana Kovářová, Zdeňka Ellederová, S J van Deventer, Harald Petry, Jan Motlík, Pavlina Konstantinova	2018	122
4	NIBP, a Novel NIK and IKKβ-binding Protein That Enhances NF-κB Activation Journal of Biological Chemistry ·Wen-Hui Hu, Julie S. Pendergast, Xian-Ming Mo, Roberta Brambilla, Valerie Bracchi‐Ricard, Fang Li, Winston Walters, Bas Blits, Li He, Sandra Marie Schaal, John R. Bethea	2005	100
5	MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain Gene Therapy ·Lluı́s Samaranch, Bas Blits, Waldy San Sebastián, Piotr Hadaczek, John R. Bringas, Vivek Sudhakar, Michael Macayan, Phillip Pivirotto, Harald Petry, Krystof S. Bankiewicz	2017	61
6	Profound Differences in Spontaneous Long-Term Functional Recovery after Defined Spinal Tract Lesions in the Rat Journal of Neurotrauma ·William T. Hendriks, Ruben Eggers, Marc J. Ruitenberg, Bas Blits, Frank P.T. Hamers, Joost Verhaagen, Gerard J. Boer	2006	54
7	Gene therapy and peripheral nerve repair: a perspective Frontiers in Molecular Neuroscience ·Stefan A. Hoyng, Fred de Winter, Martijn R. Tannemaat, Bas Blits, Martijn J. A. Malessy, Joost Verhaagen	2015	40
8	Inhibition of Semaphorin3A Promotes Ocular Dominance Plasticity in the Adult Rat Visual Cortex Molecular Neurobiology ·Elena Boggio, Erich Ehlert, Leonardo Lupori, Elizabeth B. Moloney, Fred de Winter, Craig W. Vander Kooi, Laura Baroncelli, Vasilis Mecollari, Bas Blits, James W. Fawcett, Joost Verhaagen, Tommaso Pizzorusso	2019	29
9	Apolipoprotein B Knockdown by AAV-delivered shRNA Lowers Plasma Cholesterol in Mice Molecular Therapy ·Annemart Koornneef, Piotr Maczuga, Richard van Logtenstein, Florie Borel, Bas Blits, Tita Ritsema, Sander van Deventer, Harald Petry, Pavlina Konstantinova	2011	27
10	Transduction patterns in the CNS following various routes of AAV-5-mediated gene delivery Gene Therapy ·Kimberly L. Pietersz, Raygene Martier, M. S. Baatje, Jolanda M.P. Liefhebber, Cynthia Brouwers, Stephan M. Pouw, L. Fokkert, Jacek Lubelski, Harald Petry, Gerard J.M. Martens, S J van Deventer, Pavlina Konstantinova, Bas Blits	2020	26
11	Virally Mediated Overexpression of Glial-Derived Neurotrophic Factor Elicits Age- and Dose-Dependent Neuronal Toxicity and Hearing Loss Human Gene Therapy ·Omar Akil, Bas Blits, Lawrence R. Lustig, Patricia A. Leake	2018	25
12	Embedding siRNA sequences targeting Apolipoprotein B100 in shRNA and miRNA scaffolds results in differential processing and in vivo efficacy Molecular Therapy ·Piotr Maczuga, Jacek Lubelski, Richard van Logtenstein, Florie Borel, Bas Blits, Erwin Fakkert, Adalberto Costessi, Derek Butler, Sander van Deventer, Harald Petry, Annemart Koornneef, Pavlina Konstantinova	2012	22
13	Integrin activation or alpha9 expression allows retinal pigmented epithelial cell adhesion on Bruch’s membrane in wet age-related macular degeneration Brain ·Fardad T. Afshari, Jessica C. F. Kwok, Melissa R. Andrews, Bas Blits, Keith R. Martin, Andréas Faissner, Charles ffrench‐Constant, James W. Fawcett	2010	21
14	Perspective on the Road toward Gene Therapy for Parkinson’s Disease Frontiers in Neuroanatomy ·Bas Blits, Harald Petry	2017	21
15	Titer and Product Affect the Distribution of Gene Expression after Intraputaminal Convection-Enhanced Delivery Stereotactic and Functional Neurosurgery ·Marina E. Emborg, Samuel A. Hurley, Valerie Joers, Do Tromp, Christine R. Swanson, Sachiko Ohshima-Hosoyama, Viktorya Bondarenko, Kyle Cummisford, M.A.F. Sonnemans, Stephan Hermening, Bas Blits, Andrew L. Alexander	2014	15
16	AAV-mediated in vivo knockdown of luciferase using combinatorial RNAi and U1i Gene Therapy ·Annemart Koornneef, Richard van Logtenstein, Eric Timmermans, L Pisas, Bas Blits, Xabi Abad, Puri Fortes, Harald Petry, Pavlina Konstantinova, Tita Ritsema	2011	12
17	Therapeutic expression of hairpins targeting apolipoprotein B100 induces phenotypic and transcriptome changes in murine liver Gene Therapy ·Piotr Maczuga, Joanne Verheij, Chris van der Loos, Richard van Logtenstein, Gerrit K. Hooijer, Raygene Martier, Florie Borel, Jacek Lubelski, Annemart Koornneef, Bas Blits, Sander van Deventer, Harald Petry, Pavlina Konstantinova	2013	10
18	PhP.B Enhanced Adeno-Associated Virus Mediated-Expression Following Systemic Delivery or Direct Brain Administration Frontiers in Bioengineering and Biotechnology ·Kimberly L. Pietersz, Francois du Plessis, Stephan M. Pouw, Jolanda M.P. Liefhebber, S J van Deventer, Gerard J.M. Martens, Pavlina Konstantinova, Bas Blits	2021	10
19	In-Depth Characterization of a Mifepristone-Regulated Expression System for AAV5-Mediated Gene Therapy in the Liver Molecular Therapy — Methods & Clinical Development ·Jolanda M.P. Liefhebber, Raygene Martier, Tom van der Zon, Sonay Keskin, Angelina Huseinovic, Jacek Lubelski, Bas Blits, Harald Petry, Pavlina Konstantinova	2019	4
20	Transduction profiles in minipig following MRI guided delivery of AAV-5 into thalamic and corona radiata areas Journal of Neuroscience Methods ·Kimberly L. Pietersz, Stephan M. Pouw, Jiřı́ Klı́ma, Zdeňka Ellederová, Božena Bohuslavová, Jan Chrastina, (unknown), Dušan Urgošík, Zdeněk Stárek, Michal Crha, Owen Lewis, Max Wooley, Dave Johnson, Cynthia Brouwers, Melvin M. Evers, Jan Motlík, Gerard J.M. Martens, Pavlina Konstantinova, Bas Blits	2021	1

About Bas Blits

Bas Blits is a scholar working on Cellular and Molecular Neuroscience, Immunology and Allergy, Genetics, Developmental Neuroscience and Molecular Biology, having authored 22 papers that have together received 869 indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), RNA Interference and Gene Delivery (7 papers), Nerve injury and regeneration (6 papers), CRISPR and Genetic Engineering (4 papers), RNA regulation and disease (4 papers), Viral Infections and Immunology Research (3 papers), interferon and immune responses (3 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Developmental Neuroscience (75 citations), Cellular and Molecular Neuroscience (316 citations), Clinical Biochemistry (84 citations), Molecular Biology (550 citations) and Genetics (176 citations). Bas Blits has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Harald Petry, Brendan J. Battersby, M. Pilar Bayona‐Bafaluy, Eric A. Shoubridge, Carlos T. Moraes, James W. Fawcett, Melissa R. Andrews, Charles ffrench‐Constant, Andréas Faissner and Pavlina Konstantinova. Their work appears in journals such as Gene Therapy, Molecular Therapy, Human Gene Therapy, Journal of Neuroscience and Brain.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact